The "pre-healed" and non-porous flow surface of Omniflow®II makes it impervious to tissue ingrowth and it remains patent over the long term. Omniflow II exhibits high resistance to infections and a low rate of aneurysm formation.
Combining superior patency with excellent durability and high resistance to infections, Omniflow II can reduce the number of revision procedures required in the surgical treatment of peripheral vascular disease. This provides tangible benefits both for the health-care budget as well as for the patients, who are often elderly with multiple diseases and poor operability. Omniflow II also provides an opportunity to save the saphenous vein for more demanding procedures that the patient may require in the future.
Read more
Long-term performance of Omniflow II.
Key advantages of Omniflow II.
Clinical studies on Omniflow II.
|
|